Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.

Hair conditions can be linked to diabetes and affect psychological health.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

New genetic discoveries may lead to better treatments for alopecia areata.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

New therapies are being developed that target integrin pathways to treat various diseases.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

Facelifts for Asians are challenging due to thicker, heavier skin.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Botulinum toxin may help reduce skin flap damage caused by cigarette smoke.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Finasteride may affect male fertility by interfering with specific sperm signaling.

Cordyceps militaris is a promising, cost-effective medicinal fungus with health benefits and efficient production methods.

Cucurbitacin helps mice grow hair by blocking a protein that stops hair growth.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Placenta products might help with hair loss, but more research is needed.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Plant extracts may help prevent or reverse hair graying.

Exosomes from stem cells may help rejuvenate skin and regrow hair, but more research is needed.